Novel pathogenic variants in filamin C identified in pediatric restrictive cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare and distinct form of cardiomyopathy characterized by normal ventricular chamber dimensions, normal myocardial wall thickness, and preserved systolic function. The abnormal myocardium, however, demonstrates impaired relaxation. To date, dominant variants causing RCM have been reported in a small number of sarcomeric or cytoskeletal genes, but the genetic causes in a majority of cases remain unexplained, especially in early childhood. Here, we describe two RCM families with childhood onset: one in a large family with a history of autosomal dominant RCM and the other a family with affected monozygotic, dichorionic/diamniotic twins. Exome sequencing found a pathogenic filamin C (FLNC) variant in each: p.Pro2298Leu, which segregates with disease in the large autosomal dominant RCM family, and p.Tyr2563Cys in both affected twins. In vitro expression of both mutant proteins yielded aggregates of FLNC containing actin in C2C12 myoblast cells. Recently, a number of variants in FLNC have been described that cause hypertrophic, dilated, and restrictive cardiomyopathies. Our data presented here provide further evidence for the role of FLNC in pediatric RCM, and suggest the need to include FLNC in genetic testing of cardiomyopathy patients including those with early ages of onset.

[1]  D. Frishman,et al.  De novo mutations in FLNC leading to early‐onset restrictive cardiomyopathy and congenital myopathy , 2018, Human mutation.

[2]  Kenneth L. Jones,et al.  Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures , 2018, JACC. Clinical electrophysiology.

[3]  C. Dauphin,et al.  Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy , 2017, Clinical genetics.

[4]  Robert W. Mills,et al.  Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy , 2017, Circulation. Cardiovascular genetics.

[5]  S. Ware Genetics of paediatric cardiomyopathies , 2017, Current opinion in pediatrics.

[6]  V. Álvarez,et al.  Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients , 2017, Circulation. Cardiovascular genetics.

[7]  U. Landmesser,et al.  Restrictive cardiomyopathy , 2017, Wiener klinische Wochenschrift.

[8]  N. Salomonis,et al.  Molecular Characterization of Pediatric Restrictive Cardiomyopathy from Integrative Genomics , 2017, Scientific Reports.

[9]  L. Calò,et al.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.

[10]  J. Jais,et al.  Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC. , 2016, Revue neurologique.

[11]  D. Frishman,et al.  Genetic Spectrum of Idiopathic Restrictive Cardiomyopathy Uncovered by Next-Generation Sequencing , 2016, PloS one.

[12]  X. Puente,et al.  Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C , 2016, European Journal of Human Genetics.

[13]  Kenneth L. Jones,et al.  FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy , 2016, JACC. Basic to translational science.

[14]  E. González-López,et al.  Idiopathic Restrictive Cardiomyopathy Is Primarily a Genetic Disease. , 2016, Journal of the American College of Cardiology.

[15]  R. Bryson-Richardson,et al.  Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage. , 2016, Human molecular genetics.

[16]  R. Bryson-Richardson,et al.  FLNC myofibrillar myopathy results from impaired autophagy and protein insufficiency. , 2016, Human molecular genetics.

[17]  J. Schwartzentruber,et al.  Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy , 2016, Human Mutation.

[18]  James Y. Zou Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[19]  S. Ware Evaluation of genetic causes of cardiomyopathy in childhood* , 2015, Cardiology in the Young.

[20]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[21]  Lorenzo L. Pesce,et al.  Targeted Analysis of Whole Genome Sequence Data to Diagnose Genetic Cardiomyopathy , 2014, Circulation. Cardiovascular genetics.

[22]  S. Ware,et al.  Importance of genetic evaluation and testing in pediatric cardiomyopathy. , 2014, World journal of cardiology.

[23]  X. Puente,et al.  Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy , 2014, Nature Communications.

[24]  R. Krijger,et al.  Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects , 2014, European Journal of Human Genetics.

[25]  Gert Vriend,et al.  YASARA View—molecular graphics for all devices—from smartphones to workstations , 2014, Bioinform..

[26]  Marco Biasini,et al.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..

[27]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[28]  S. Heymans,et al.  Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy. , 2013, Cardiovascular research.

[29]  P. Elliott,et al.  Restrictive cardiomyopathy and hypertrophic cardiomyopathy overlap: the importance of the phenotype , 2012 .

[30]  J. Miller,et al.  Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.

[31]  S. Colan,et al.  Outcomes of Restrictive Cardiomyopathy in Childhood and the Influence of Phenotype: A Report From the Pediatric Cardiomyopathy Registry , 2012, Circulation.

[32]  I. Ferrer,et al.  Pathophysiology of protein aggregation and extended phenotyping in filaminopathy. , 2012, Brain : a journal of neurology.

[33]  L. Waddell,et al.  Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late‐onset cerebellar ataxia , 2012, Muscle & nerve.

[34]  J. Ylänne,et al.  Filamins in mechanosensing and signaling. , 2012, Annual review of biophysics.

[35]  Hanns Lochmüller,et al.  Distal myopathy with upper limb predominance caused by filamin C haploinsufficiency , 2011, Neurology.

[36]  J. Towbin,et al.  Genetics of cardiomyopathies in children , 2011 .

[37]  L. Leinwand,et al.  Cellular mechanisms of cardiomyopathy , 2011, The Journal of cell biology.

[38]  H. Calkins,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Heart rhythm.

[39]  Robert H. Brown,et al.  Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. , 2011, American journal of human genetics.

[40]  Gert Vriend,et al.  Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces , 2010, BMC Bioinformatics.

[41]  S. Webber,et al.  Restrictive cardiomyopathy in childhood. , 2010, Heart failure clinics.

[42]  R. Kley,et al.  The sarcomeric Z-disc component myopodin is a multiadapter protein that interacts with filamin and alpha-actinin. , 2010, European journal of cell biology.

[43]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[44]  Wei Zhang,et al.  A novel heterozygous deletion–insertion mutation (2695–2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family , 2010, Neuromuscular Disorders.

[45]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[46]  M. Hoch,et al.  Chaperone-Assisted Selective Autophagy Is Essential for Muscle Maintenance , 2010, Current Biology.

[47]  I. Ferrer,et al.  In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy , 2009, European Journal of Human Genetics.

[48]  C. Heyer,et al.  Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. , 2007, Brain : a journal of neurology.

[49]  M. Vorgerd,et al.  The pathomechanism of filaminopathy: altered biochemical properties explain the cellular phenotype of a protein aggregation myopathy. , 2007, Human molecular genetics.

[50]  V. Rybin,et al.  Crystal structure of human filamin C domain 23 and small angle scattering model for filamin C 23-24 dimer. , 2007, Journal of molecular biology.

[51]  Stefan Eulitz,et al.  Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP. , 2006, Experimental cell research.

[52]  S. Webber,et al.  Idiopathic restrictive cardiomyopathy in children , 2005, Heart.

[53]  Hanns Lochmüller,et al.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.

[54]  C. Walsh,et al.  The many faces of filamin: A versatile molecular scaffold for cell motility and signalling , 2004, Nature Cell Biology.

[55]  C. Freed,et al.  Tyrosine-to-Cysteine Modification of Human α-Synuclein Enhances Protein Aggregation and Cellular Toxicity* , 2004, Journal of Biological Chemistry.

[56]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[57]  F. Hanefeld,et al.  Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle , 2003, Journal of the Neurological Sciences.

[58]  T. Helliwell,et al.  The spectrum of pathology in central core disease , 2002, Neuromuscular Disorders.

[59]  J. Hartwig,et al.  Filamins as integrators of cell mechanics and signalling , 2001, Nature Reviews Molecular Cell Biology.

[60]  Simon C Watkins,et al.  Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein , 2000 .

[61]  C. Deber,et al.  Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Hecht,et al.  De novo design of beta-sheet proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Fishbein,et al.  Idiopathic restrictive cardiomyopathy. , 1984, Circulation.

[64]  J. Wilkinson,et al.  The Value of National Institutes of Health (NIH) Registry-Based Research in Identifying Childhood Cardiac Disease Outcomes: The Pediatric Cardiomyopathy Registry Experience , 2015 .

[65]  J. Towbin Inherited cardiomyopathies. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[66]  L. Goldfarb,et al.  DNA sequencing errors in molecular diagnostics of filamin myopathy , 2010, Clinical chemistry and laboratory medicine.

[67]  V. Moiseev [Genetics of cardiomyopathies]. , 2003, Kardiologiia.

[68]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[69]  L. Leinwand,et al.  The cell biology of disease Cellular mechanisms of cardiomyopathy , 2022 .